Company
Apollo Endosurgery
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
8
510(k), De Novo and PMA
Device trials
6
As lead sponsor, any status
Adverse event reports
179
Received Nov 1, 2025 to Nov 20, 2026
Recall records
2
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$160M
7 Form D offerings, 2009 to 2020
Equity
$132M
Stock sold for cash
Debt and convertible notes
$28.0M
$25.0M of it convertible
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: equity, $25.0M raised of $25.0M sought, first sale Jul 21, 2020, 18 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Jul 21, 2020 | Equity | $25.0M | $25.0M | 18 | Rule 506(b)Agent: Craig-Hallum Capital Group LLCCommissions $1.6M | Form D ↗Jul 30, 2020 |
| Aug 12, 2019 | Convertible note | $20.0M | $20.0M | 18 | Rule 506(b)Agent: Craig-Hallum Capital Group LLCCommissions $1.3M | Form D ↗Aug 27, 2019 |
| Dec 29, 2016 | Equity | $54.4M | $54.4M | 15 | Rule 506(b) | Form D ↗Jan 11, 2017 |
4 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- Apollo Endosurgery, Inc.; APOLLO ENDOSURGERY US INC
- Headquarters
- Austin, Texas
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Biotechnology
- SEC filer
- CIK 1251769 ↗, CIK 1369432 ↗
Executives, directors and promoters
As listed on the latest Form D.
12 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Apollo Endosurgery.
Latest FDA decisions
K232544 · Decided Sep 18, 2023 · 27 days after receipt
Device type: Endoscopic Suturing Device For Altering Gastric Anatomy For Weight Loss (QTD) · GI, Urology & Nephrology
K231553 · Decided Jun 29, 2023 · 30 days after receipt
Device type: Endoscopic Tissue Approximation Device (OCW) · GI, Urology & Nephrology
- APOLLO ESG System, APOLLO ESG SX System, APOLLO REVISE System, APOLLO REVISE SX SystemNew device typeDe Novo
DEN210045 · Decided Jul 12, 2022 · 285 days after receipt
Device type: Endoscopic Suturing Device For Altering Gastric Anatomy For Weight Loss (QTD) · GI, Urology & Nephrology
5 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT04362774 · 25 participants · Start Feb 23, 2021 · Primary completion Feb 21, 2023
Device: ORBERA365 · For: Obesity; Overweight
Sites: Seville, Spain
NCT00953173 · 671 participants · Start Dec 2009 · Primary completion Jul 2016
Device: LAP-BAND AP® Adjustable Gastric Banding System · For: Obesity
Sites: Everett, Washington; Adelaide, Australia; Jette, Belgium · 6 sites in all
- A Study of BioEnterics® Intragastric Balloon (BIB®) System to Assist in the Weight Management of Obese SubjectsPivotal-lookingCompleted
NCT00730327 · 448 participants · Start Jun 2008 · Primary completion Oct 2011
Device: BioEnterics® Intragastric Balloon · For: Obesity
Sites: Austin, Texas
3 more trials with a free account
Reports received
179
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
110
61% of reports
Injury reports
69
39% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 12 | 13 | 0 | 0 |
| Jan 24 | 11 | 17 | 0 | 0 |
| Feb 24 | 12 | 4 | 0 | 0 |
| Mar 24 | 19 | 3 | 0 | 0 |
| Apr 24 | 13 | 4 | 1 | 0 |
| May 24 | 10 | 5 | 1 | 0 |
| Jun 24 | 4 | 10 | 1 | 0 |
| Jul 24 | 6 | 3 | 0 | 0 |
| Aug 24 | 21 | 9 | 0 | 0 |
| Sep 24 | 4 | 8 | 0 | 0 |
| Oct 24 | 12 | 8 | 1 | 0 |
| Nov 24 | 2 | 4 | 0 | 0 |
| Dec 24 | 3 | 12 | 0 | 0 |
| Jan 25 | 12 | 9 | 0 | 0 |
| Feb 25 | 8 | 12 | 0 | 0 |
| Mar 25 | 11 | 14 | 0 | 0 |
| Apr 25 | 5 | 3 | 0 | 0 |
| May 25 | 7 | 4 | 0 | 0 |
| Jun 25 | 9 | 3 | 0 | 0 |
| Jul 25 | 15 | 10 | 0 | 0 |
| Aug 25 | 8 | 7 | 0 | 0 |
| Sep 25 | 5 | 5 | 0 | 0 |
| Oct 25 | 9 | 5 | 2 | 0 |
| Nov 25 | 13 | 9 | 0 | 0 |
| Dec 25 | 19 | 7 | 0 | 0 |
| Jan 26 | 11 | 6 | 0 | 0 |
| Feb 26 | 18 | 10 | 0 | 0 |
| Mar 26 | 6 | 1 | 0 | 0 |
| Apr 26 | 3 | 6 | 0 | 0 |
| May 26 | 5 | 4 | 0 | 0 |
| Jun 26 | 2 | 2 | 0 | 0 |
| Jul 26 | 15 | 6 | 0 | 0 |
| Aug 26 | 4 | 3 | 0 | 0 |
| Sep 26 | 11 | 5 | 0 | 0 |
| Oct 26 | 3 | 10 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2743-2018 · Started Nov 22, 2017
Reason given: Component of the Lap-Band system was missing from the package
Cause as FDA categorized it: Under Investigation by firm · Device type: Implant, Intragastric For Morbid Obesity (LTI)
Z-2732-2014 · Started Aug 15, 2014 · Posted by FDA Sep 30, 2014
Reason given: Product was distributed past its expiration date.
Cause as FDA categorized it: Software Manufacturing/Software Deployment · Device type: Implant, Intragastric For Morbid Obesity (LTI)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.